#19 Practical RWE – Regulatory Green Light

 

The regulatory green light in the context of non-interventional studies plays a crucial role in ensuring that these studies are conducted ethically, legally, and responsibly. Despite the absence of an investigational medicinal product, which might suggest a simpler regulatory path compared to interventional studies, non-interventional studies still require rigorous oversight. This oversight is critical for several reasons:

[1] Ethical Considerations

Non-interventional studies, like all research involving human participants, are subject to ethical principles outlined in the Declaration of Helsinki. These principles are designed to protect the rights, safety, and well-being of research participants. The regulatory green light process ensures that research ethics committees (or institutional review boards) have reviewed the study’s ethical aspects, including the information provided to participants and the consent process. This step is vital to ensure that participants are fully informed about the study’s nature, their rights, and the use of their data, allowing them to make an informed decision about their participation.

[2] Legal Compliance

The approval process also verifies compliance with local laws and regulations governing research with human subjects. By obtaining the necessary approvals, study sponsors and investigators ensure that their study is legally permissible, protecting both the participants and the research entities from legal repercussions. This compliance extends to contractual agreements with research sites, further formalizing the study’s legal and ethical framework.

[3] Participant Recruitment and Data Collection

The regulatory green light signifies that all prerequisites for starting the study have been met, allowing for the ethical recruitment of participants and collection of data. This step is critical to ensure that the study can proceed smoothly without ethical or legal issues that could compromise the research’s integrity or necessitate its cessation.

[4] Moral and Professional Responsibility

Study sponsors and project managers bear a moral and professional obligation to ensure that their research adheres to the highest ethical and legal standards. This responsibility includes securing all necessary approvals before initiating any study activities. Failure to do so not only undermines the study’s ethical foundation but also risks damaging public trust in research practices and potentially harming participants.

[5] Ensuring Data Integrity and Research Validity

Regulatory approvals contribute to the integrity and validity of the research. Studies conducted with proper ethical and legal oversight are more likely to be recognized and accepted by the scientific community, regulatory authorities, and the public. This acceptance is crucial for the impact of the study’s findings on policy, clinical practice, or further research.

In summary, the regulatory green light in non-interventional studies is not merely a bureaucratic step; it is a fundamental component of responsible research conduct. It ensures ethical integrity, legal compliance, participant protection, and the overall validity of the study’s findings, highlighting the importance of this process in the broader context of generating reliable real-world evidence (RWE).

Share this story...
EU – EMA’s 2025 Vision for RWE

November 5, 2023|2023, RWE 201|

RWE 201 - EU – EMA’s 2025 Vision for RWE   EMA 2025 Vision: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299492/ EMA RWE Framework Report: https://www.ema.europa.eu/en/documents/report/real-world-evidence-framework-support-eu-regulatory-decision-making-report-experience-gained_en.pdf The European Medicines Agency (EMA) isn't simply relying [...]

EU – The Data Governance Act

October 14, 2023|2023, RWE 201|

RWE 201 - EU – The Data Governance Act  Data Governance Act: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0868The EU Data Governance Act (DGA) aims to establish a legal framework for data sharing across sectors. [...]

EU – The European Health Data Space

October 14, 2023|2023, RWE 201|

RWE 201 - EU - The European Health Data Space [Image Source: https://tehdas.eu/results/tehdas-identifies-user-journey-for-cross-border-health-data-sharing/]EHDS: https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space_enThe European Health Data Space (EHDS) is an initiative by the European Commission to foster the [...]

EU – EU4Health Program

October 14, 2023|2023, RWE 201|

RWE 201 - EU - EU4Health Program EU4Health: https://health.ec.europa.eu/funding/eu4health-programme-2021-2027-vision-healthier-european-union_enEU4Health is an ambitious EU health program for the years 2021-2027. Its primary goal is to bolster the resilience of Europe's [...]